Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshima Z Parris

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|October 12, 2013
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z Parris, Anikó Kovács, Luaay Aziz, et al.
BMC Cancer|June 3, 2014
Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaToshima Z Parris, Luaay Aziz, Anikó Kovács, et al.
Case Reports in Oncology|December 28, 2017
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic AnalysisJenny Nyqvist, Fredrik Persson, Toshima Z Parris, et al.
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
Scientific Reports|April 4, 2020
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screensPeter Larsson, Hanna Engqvist, Jana Biermann, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Molecular Therapy. Oncology|April 30, 2026
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesisElla Ittner, Lucas Werner, Hugo Swenson, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Breast Cancer Research : BCR|April 6, 2023
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancerSlavica Janeva, Ellen Krabbe, Toshima Z Parris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2017
A Novel 18-Marker Panel Predicting Clinical Outcome in Breast CancerJana Biermann, Szilárd Nemes, Toshima Z Parris, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|October 12, 2013
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z Parris, Anikó Kovács, Luaay Aziz, et al.
BMC Cancer|June 3, 2014
Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaToshima Z Parris, Luaay Aziz, Anikó Kovács, et al.
Case Reports in Oncology|December 28, 2017
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic AnalysisJenny Nyqvist, Fredrik Persson, Toshima Z Parris, et al.
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
Scientific Reports|April 4, 2020
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screensPeter Larsson, Hanna Engqvist, Jana Biermann, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Molecular Therapy. Oncology|April 30, 2026
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesisElla Ittner, Lucas Werner, Hugo Swenson, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Breast Cancer Research : BCR|April 6, 2023
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancerSlavica Janeva, Ellen Krabbe, Toshima Z Parris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2017
A Novel 18-Marker Panel Predicting Clinical Outcome in Breast CancerJana Biermann, Szilárd Nemes, Toshima Z Parris, et al.
Pageof 8